These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19803554)

  • 1. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.
    Gleason PP; Starner CI; Gunderson BW; Schafer JA; Sarran HS
    J Manag Care Pharm; 2009 Oct; 15(8):648-58. PubMed ID: 19803554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis.
    Hopson S; Saverno K; Liu LZ; AL-Sabbagh A; Orazem J; Costantino ME; Pasquale MK
    J Manag Care Spec Pharm; 2016 Feb; 22(2):122-30. PubMed ID: 27015251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers.
    Zhang D; Carlson AM; Gleason PP; Schondelmeyer SW; Schommer JC; Dowd BE; Heaton AH
    J Manag Care Pharm; 2007 Oct; 13(8):664-76. PubMed ID: 17970604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit.
    Spence MM; Hui R; Chan J
    J Manag Care Pharm; 2006 Jun; 12(5):377-82. PubMed ID: 16792444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir initial therapy abandonment and manufacturer coupons in a commercially insured population.
    Karmarkar TD; Starner CI; Qiu Y; Tiberg K; Gleason PP
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP191-7. PubMed ID: 27266948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
    Klepser DG; Huether JR; Handke LJ; Williams CE
    J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007.
    Kunze AM; Gunderson BW; Gleason PP; Heaton AH; Johnson SV
    J Manag Care Pharm; 2007; 13(9):799-806. PubMed ID: 18062731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
    Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
    J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions.
    Streeter SB; Schwartzberg L; Husain N; Johnsrud M
    Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP38-44. PubMed ID: 21711076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents.
    Doshi JA; Li P; Huo H; Pettit AR; Armstrong KA
    J Clin Oncol; 2018 Feb; 36(5):476-482. PubMed ID: 29261440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system.
    Brouwer E; Yeung K; Barthold D; Hansen R
    J Manag Care Spec Pharm; 2021 Jun; 27(6):732-742. PubMed ID: 34057391
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of out-of-pocket pharmacy costs with adherence to varenicline.
    Suehs BT; Davis C; Galaznik A; Joshi AV; Zou KH; Patel NC
    J Manag Care Spec Pharm; 2014 Jun; 20(6):592-600. PubMed ID: 24856597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health plan utilization and costs of specialty drugs within 4 chronic conditions.
    Gleason PP; Alexander GC; Starner CI; Ritter ST; Van Houten HK; Gunderson BW; Shah ND
    J Manag Care Pharm; 2013 Sep; 19(7):542-8. PubMed ID: 23964615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
    Starner CI; Alexander GC; Bowen K; Qiu Y; Wickersham PJ; Gleason PP
    Health Aff (Millwood); 2014 Oct; 33(10):1761-9. PubMed ID: 25288420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.